Obstructive Sleep Apnea (OSA) Clinical Trial
— AVDOfficial title:
Effects of Audiovisual Distraction Versus Standard Sedation on Desaturation and Airway Intervention in OSA-patients Undergoing Total Knee Arthroplasty Under Neuraxial Anesthesia
NCT number | NCT03020914 |
Other study ID # | 2016-0648 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2017 |
Est. completion date | May 2019 |
Verified date | May 2022 |
Source | Hospital for Special Surgery, New York |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Patients will be randomly assigned to either one of two groups: 1. Standard of care sedation 2. Audiovisual distraction during surgery and in the recovery room using video goggles and headphones; patients can choose a movie from a preexisting library Monitoring and anesthesia regimen will be standardized
Status | Completed |
Enrollment | 19 |
Est. completion date | May 2019 |
Est. primary completion date | May 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Patients with known OSA (preexisting diagnosis of obstructive sleep apnea (OSA) or patients with a STOP BANG Score of 5 or above) undergoing primary total knee arthroplasty under neuraxial anesthesia Exclusion Criteria: - Contraindications to neuraxial anesthesia or allergy to study medication - Patients with audiovisual impairments prohibiting them from proper use of the study device: - Patients who are blind - Patients with hearing aids - Age <18 years - Patients with inability to communicate in English or understand the study requirements - Patients with prior history of claustrophobia - Patients with prior history of epilepsy or seizure disorder - Patients undergoing a revision |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Hospital for Special Surgery, New York |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Desaturations | number of desaturation events (SpO2< 90% for = 10 sec) measured during this time frame | start of anesthesia until 30 minutes after recovery room admission (ca. 3 hours) | |
Secondary | Airway Interventions | each airway intervention (defined as one of the following: jaw thrust, oropharyngeal airway, nasopharyngeal airway, mask ventilation, larynx mask or intubation) that is implemented during this time frame will be observed and documented by research staff, if it occurs. | start of anesthesia until 30 minutes after recovery room admission (ca. 3 hours) | |
Secondary | Additional Sedation | Patient request for additional sedation | intraoperative | |
Secondary | Patient Satisfaction | Patient satisfaction at recovery room discharge as measured by the Heidelberg perianesthetic questionnaire, which assesses patients' peri-anaesthetic satisfaction on a four-point Likert scale ranging from 0 (unimportant to me) to 3 (very important to me). Scores for each question are summed for a final score, with higher total score signifying higher satisfaction and lower total score signifying lower satisfaction. The score scale has a minimum value of 0 and a maximum value of 114 (based off 3 as the highest response score for 38 individual questions). | 10 minutes before recovery room discharge | |
Secondary | Alertness Levels | Alertness levels measured using the Modified Observer's Assessment of Alertness/Sedation Scale (MOAA/S), which rates alertness on a scale of 0-5, with higher ratings representing increased alertness (e.g. '5 - Responds readily to name spoken in normal tone'). Results reflect a median score of ratings collected at 4 time points. | 4 times: preoperative, intraoperative, at time of recovery room admission, 10 minutes before recovery room discharge |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT04939168 -
Measuring Atomoxetine and Aroxybutynin In Patients With OSA
|
Phase 2 | |
Completed |
NCT02908529 -
Atomoxetine and Oxybutynin in Obstructive Sleep Apnea
|
Phase 1/Phase 2 | |
Completed |
NCT03415633 -
Validity of a Home Respiratory Polygraphy for the Diagnosis of Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT03426631 -
DAW1033B2 in Obstructive Sleep Apnea
|
Phase 1/Phase 2 | |
Completed |
NCT04206449 -
Sleep Thermography for Diagnosis of Obstructive Sleep Apnea (TERMOAPNEA)
|
N/A | |
Active, not recruiting |
NCT03018912 -
Validating the Use of a Subjectively Reported Sleep Vital Sign
|
N/A | |
Completed |
NCT02549508 -
Comparison Study Using APAP With and Without SensAwake in Patients With OSA and PTSD
|
N/A | |
Completed |
NCT01249924 -
The Effectiveness of Perioperative CPAP to Reduce Obstructive Sleep Apnea Related Adverse Events
|
N/A | |
Completed |
NCT00773721 -
Foam Mask - Assessment of Bioburden in a New Mask Seal Material
|
N/A | |
Completed |
NCT02314858 -
Tailored Treatment to Enhance Risk Perception in Sleep Apnea
|
N/A | |
Completed |
NCT01476917 -
The ATLAST Long-Term Study
|
Phase 2/Phase 3 | |
Terminated |
NCT00730041 -
Palatal Implants in Combination With Continuous Positive Airway Pressure to Treat Obstructive Sleep Apnea
|
Phase 4 | |
Completed |
NCT00850434 -
Improved Automatic CPAP Algorithm to Treat Obstructive Sleep Apnea (OSA)
|
N/A | |
Enrolling by invitation |
NCT04538755 -
DAW2020 on OSA Endotypic Traits
|
Phase 1/Phase 2 | |
Completed |
NCT02501304 -
Feasibility Study of the ReVENT Sleep Apnea System
|
N/A | |
Withdrawn |
NCT02805777 -
Vent Flow Study of Prototype Nasal CPAP Mask
|
N/A | |
Completed |
NCT02097212 -
Correlation Between Trachebroncho Malacia/Hyperdynamic Airway Collapse And Obstructive Sleep Apnea
|
N/A | |
Active, not recruiting |
NCT02295306 -
Overnight Polysomnography and Respiratory Volume Monitor
|
||
Completed |
NCT01939938 -
Pilot Study of the Comparison of the Upper Airway Dynamics of Oronasal vs Nasal Masks With PAP Treatment
|
N/A | |
Terminated |
NCT01877928 -
Post-extubation Boussignac CPAP System in Adults With Moderate to Severe Obstructive Sleep Apnea
|
N/A |